MGManoj K. Gottipati

Manoj K. Gottipati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manoj K. Gottipati has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Vladimir Parpura

    International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University, Hangzhou 310053, China

    8 shared publications
  • Elena Bekyarova

    Department of Chemistry and Department of Chemical Engineering, Center for Nanoscale Science and Engineering, University of California, Riverside, USA

    4 shared publications
  • Robert C. Haddon

    Center for Nanoscale Science and Engineering, University of California - Riverside, Riverside, California 92521, USA

    4 shared publications
  • Ryan J. Gilbert

    Biomedical Engineering Department, Rensselaer Polytechnic Institute, 110 8th Street, Troy, New York, 12180, UNITED STATES

    4 shared publications
  • Vladimir Parpura

    Department of Neurobiology, University of Alabama, Birmingham, AL 35294, United States; Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia

    4 shared publications
  • Alexis M. Ziemba

    Center for Biotechnology and Interdisciplinary Sciences, Rensselaer Polytechnic Institute, 1623 15th Street, Troy, New York 12180, United States

    2 shared publications

Latest Publications

  • Open Access

    Electrospun Fiber Scaffolds for Engineering Glial Cell Behavior to Promote Neural Regeneration

    by Devan L. Puhl, Jessica L. Funnell, Derek W. Nelson, Manoj K. Gottipati, Ryan J. Gilbert

    Electrospinning is a fabrication technique used to produce nano- or micro- diameter fibers to generate biocompatible, biodegradable scaffolds for tissue engineering applications. Electrospun fiber scaffolds are advantageous for neural regeneration because they mimic the structure of the nervous system extracellular matrix and provide contact guidance for regenerating axons. Glia are non-neuronal regulatory cells that maintain homeostasis in the healthy nervous system and regulate regeneration in the injured nervous system. Electrospun fiber scaffolds offer a wide range of characteristics, such as fiber alignment, diameter, surface nanotopography, and surface chemistry that can be engineered to achieve a desired glial cell response to injury. Further, electrospun fibers can be loaded with drugs, nucleic acids, or proteins to provide the local, sustained release of such therapeutics to alter glial cell phenotype to better support regeneration. This review provides the first comprehensive overview of how electrospun fiber alignment, diameter, surface nanotopography, surface functionalization, and therapeutic delivery affect Schwann cells in the peripheral nervous system and astrocytes, oligodendrocytes, and microglia in the central nervous system both in vitro and in vivo. The information presented can be used to design and optimize electrospun fiber scaffolds to target glial cell response to mitigate nervous system injury and improve regeneration.


  • Conventional immunomarkers stain a fraction of astrocytes in vitro: A comparison of rat cortical and spinal cord astrocytes in naïve and stimulated cultures

    by Bailey Balouch, Jessica L. Funnell, Alexis M. Ziemba, Devan L. Puhl, Kathy Lin, Manoj K. Gottipati, Ryan J. Gilbert

    Astrocytes are responsible for a wide variety of essential functions throughout the central nervous system. The protein markers glial fibrillary acidic protein (GFAP), glutamate aspartate transporter (GLAST), glutamate transporter‐1 (GLT‐1), glutamine synthetase (GS), 10‐formyltetrahydrofolate dehydrogenase (ALDH1L1), and the transcription factor SOX9 are routinely used to label astrocytes in primary rodent cultures. However, GLAST, GLT‐1, GS, and SOX9 are also produced by microglia and oligodendrocytes and GFAP, GLAST, GLT‐1, and GS production levels are affected by astrocyte phenotypic changes associated with reactive astrogliosis. No group has performed a comprehensive immunocytochemical evaluation to quantify the percentage of cells labeled by these markers in vitro, nor compared changes in staining between cortex‐ and spinal cord‐derived cells in naïve and stimulated cultures. Here, we quantified the percentage of cells positively stained for these six markers in astrocyte, microglia, and oligodendrocyte cultures isolated from neonatal rat cortices and spinal cords. Additionally, we incubated the astrocytes with transforming growth factor (TGF)‐β1 or TGF‐β3 to determine if the labeling of these markers is altered by these stimuli. We found that only SOX9 in cortical cultures and ALDH1L1 in spinal cord cultures labeled more than 75% of the cells in naïve and stimulated astrocyte cultures and stained less than 5% of the cells in microglia and oligodendrocyte cultures. Furthermore, significantly more cortical than spinal cord astrocytes stained for GFAP, GLAST, and ALDH1L1 in naïve cultures, whereas significantly more spinal cord than cortical astrocytes stained for GLAST and GS in TGF‐β1‐treated cultures. These findings are important as variability in marker staining may lead to misinterpretation of the astrocyte response in cocultures, migration assays, or engineered disease models.


  • Open Access

    Human immune cells infiltrate the spinal cord and impair recovery after spinal cord injury in humanized mice

    by Randall S. Carpenter, Roselyn R. Jiang, Faith H. Brennan, Jodie C. E. Hall, Manoj K. Gottipati, Stefan Niewiesk, Phillip G. Popovich

    Humanized mice can be used to better understand how the human immune system responds to central nervous system (CNS) injury and inflammation. The optimal parameters for using humanized mice in preclinical CNS injury models need to be established for appropriate use and interpretation. Here, we show that the developmental age of the human immune system significantly affects anatomical and functional outcome measures in a preclinical model of traumatic spinal cord injury (SCI). Specifically, it takes approximately 3–4 months for a stable and functionally competent human immune system to develop in neonatal immune compromised mice after they are engrafted with human umbilical cord blood stem cells. Humanized mice receiving a SCI before or after stable engraftment exhibit significantly different neuroinflammatory profiles. Importantly, the development of a mature human immune system was associated with worse lesion pathology and neurological recovery after SCI. In these mice, human T cells infiltrate the spinal cord lesion and directly contact human macrophages. Together, data in this report establish an optimal experimental framework for using humanized mice to help translate promising preclinical therapies for CNS injury.


  • Open Access

    Human immune cells infiltrate the lesioned spinal cord and impair recovery after spinal cord injury in humanized mice

    by Randall S. Carpenter, Roselyn R. Jiang, Faith H. Brennan, Jodie C.E. Hall, Manoj K. Gottipati, Stefan H. Niewiesk, Phillip G. Popovich

    Summary Points: Immune compromised mice require ~4 months of engraftment with human umbilical cord blood CD34 + stem cells to develop a full and functional human immune system The human neuroinflammatory response elicited after spinal cord injury in humanized mice is limited at 2 months post-engraftment but matures by 4 months Intraspinal neuroinflammation consists of a florid human T cell and macrophage response, and human T cells co-localize with human macrophages A human intraspinal neuroinflammatory response exacerbates lesion pathology and impairs functional recovery Humanized mice are a useful tool to help better understand how the human immune system responds to central nervous system (CNS) injury. However, the optimal parameters for using humanized mice in preclinical CNS injury models have not been established. Here, we show that it takes 3-4 months after engraftment of neonatal immune compromised mice with human umbilical cord stem cells to generate a robust human immune system. Indeed, sub-optimal human immune cell responses occurred when humanized mice received spinal contusion injuries at 2 months vs. 4 months post-engraftment. Human T cells directly contact human macrophages within the spinal cord lesion of these mice and the development of a mature human immune system was associated with worse lesion pathology and neurological recovery. Together, data in this report establish an optimal experimental framework for using humanized mice to help translate promising preclinical therapies for CNS injury.


  • Open Access

    Biomaterial Approaches to Modulate Reactive Astroglial Response

    by Jonathan M. Zuidema, Ryan J. Gilbert, Manoj K. Gottipati

    Over several decades, biomaterial scientists have developed materials to spur axonal regeneration and limit secondary injury and tested these materials within preclinical animal models. Rarely, though, are astrocytes examined comprehensively when biomaterials are placed into the injury site. Astrocytes support neuronal function in the central nervous system. Following an injury, astrocytes undergo reactive gliosis and create a glial scar. The astrocytic glial scar forms a dense barrier which restricts the extension of regenerating axons through the injury site. However, there are several beneficial effects of the glial scar, including helping to reform the blood-brain barrier, limiting the extent of secondary injury, and supporting the health of regenerating axons near the injury site. This review provides a brief introduction to the role of astrocytes in the spinal cord, discusses astrocyte phenotypic changes that occur following injury, and highlights studies that explored astrocyte changes in response to biomaterials tested within in vitro or in vivo environments. Overall, we suggest that in order to improve biomaterial designs for spinal cord injury applications, investigators should more thoroughly consider the astrocyte response to such designs.


  • Open Access

    Effects of Chemically-Functionalized Single-Walled Carbon Nanotubes on the Morphology and Vitality of D54MG Human Glioblastoma Cells

    by Seantel Hopkins, Manoj K. Gottipati, Vedrana Montana, Elena Bekyarova, Robert C. Haddon, Vladimir Parpura

    The unique properties of single-walled carbon nanotubes (SWCNTs) have made them interesting candidates for applications in biomedicine. There are diverse chemical groups that can be attached to SWCNTs in order for these tiny tubes to gain various functionalities, for example, water solubility. Due to the availability of these “functionalization” approaches, SWCNTs are seen as agents for a potential anti-cancer therapy. In this context, we tested different chemically-functionalized forms of SWCNTs to determine which modifications make them better combatants against glioblastoma (astrocytoma grade IV), the deadliest brain cancer. We investigated the effects that two types of water soluble SWCNTs, functionalized with polyethylene glycol (SWCNT-PEG) or tetrahydrofurfuryl-terminated polyethylene glycol (SWCNT-PEG-THFF), have on the morphology and vitality, that is, cell adhesion, proliferation and death rate, of the D54MG human glioblastoma cells in culture. We found that SWCNT-PEG-THFF solute, when added to culture media, makes D54MG cells less round (measured as a significant decrease, by ~23%, in the form factor). This morphological change was induced by the PEG-THFF functional group, but not the SWCNT backbone itself. We also found that SWCNT-PEG-THFF solute reduces the proliferation rate of D54MG cells while increasing the rate of cell death. The functional groups PEG and PEG-THFF, on the other hand, reduce the cell death rate of D54MG human glioma cells. These data indicate that the process of functionalization of SWCNTs for potential use as glioma therapeutics may affect their biological effects.


  • Intraspinal TLR4 activation promotes iron storage but does not protect neurons or oligodendrocytes from progressive iron-mediated damage

    by Evan Z. Goldstein, Jamie S. Church, Nicole Pukos, Manoj K. Gottipati, Phillip G. Popovich, Dana M. McTigue


  • Sophorolipid Butyl Ester Diacetate Does Not Affect Macrophage Polarization but Enhances Astrocytic Glial Fibrillary Acidic Protein Expression at Micromolar Concentrations in Vitro

    by Alexis M. Ziemba, Manoj K. Gottipati, Filbert Totsingan, Cheryl M. Hanes, Richard A. Gross, Michelle R. Lennartz, Ryan J. Gilbert

    Peritoneal macrophages (PMACs) and spinal cord astrocytes were exposed to varying concentrations of soluble sophorolipid butyl ester diacetate (SLBEDA) in vitro. Macrophages and astrocytes demonstrated no decrease in viability in response to SLBEDA. Studying pro- and anti-inflammatory genes, PMACs did not show a shift toward a pro-inflammatory phenotype. However, at higher concentrations (3 and 30 μM), astrocytes showed an increase in their expression of glial acidic fibrillary protein. This novel category of compounds poses low risk to PMAC and astrocyte viability; however, the effect on PMAC polarization and astrocyte reactivity requires more elucidation.


  • Open Access

    Mathematical Modeling in Neuroscience: Neuronal Activity and Its Modulation by Astrocytes

    by Shivendra G. Tewari, Manoj K. Gottipati, Vladimir Parpura

    Mathematical Modeling in Neuroscience: Neuronal Activity and Its Modulation by Astrocytes